ArticleMedical & biological engineering & computing2025
Non-parametric Bayesian deep learning approach for whole-body low-dose PET reconstruction and uncertainty assessment.
Article in Medical & biological engineering & computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deep unrolled regularization for limited-angle dual-panel positron emission mammography.Physical and engineering sciences in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Positron emission tomography (PET) imaging plays a pivotal role in oncology for the early detection of metastatic tumors and response to therapy assessment due to its high sensitivity compared to anatomical imaging modalities. The balance between image quality and radiation exposure is critical, as reducing the administered dose results in a lower signal-to-noise ratio (SNR) and information loss, which may significantly affect clinical diagnosis. Deep learning (DL) algorithms have recently made significant progress in low-dose (LD) PET reconstruction. Nevertheless, a successful clinical application requires a thorough evaluation of uncertainty to ensure informed clinical judgment. We propose NPB-LDPET, a DL-based non-parametric Bayesian framework for LD PET reconstruction and uncertainty assessment. Our framework utilizes an Adam optimizer with stochastic gradient Langevin dynamics (SGLD) to sample from the underlying posterior distribution. We employed the Ultra-low-dose PET Challenge dataset to assess our framework's performance relative to the Monte Carlo dropout benchmark. We evaluated global reconstruction accuracy utilizing SSIM, PSNR, and NRMSE, local lesion conspicuity using mean absolute error (MAE) and local contrast, and the clinical relevance of uncertainty maps employing correlation between the uncertainty measures and the dose reduction factor (DRF). Our NPB-LDPET reconstruction method exhibits a significantly superior global reconstruction accuracy for various DRFs (paired t-test,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.